Clinical Trial Update: Rivastigmine Mini-Tablet for Alzheimer's Disease

View source ↗

Summary

Clinical trial update indicates rivastigmine mini-tablet for Alzheimer's disease is not yet recruiting, sponsored by Peking University First Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Rivastigmine mini-tablet (rivastigmine)

Snippet

Sponsor: Peking University First Hospital | Conditions: Alzheimer's Disease | Status: NOT_YET_RECRUITING